Economic burden of hepatitis C in Canada and the potential impact of prevention-Reference-Cited by-同舟云学术

Economic burden of hepatitis C in Canada and the potential impact of prevention

Published:2005-06 Issue:2 Volume:6 Page:159-165
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

El Saadany Susie,Coyle Douglas,Giulivi Antonio,Afzal Mohammad

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-004-0273-y.pdf

Reference27 articles.

1. Zou S, Tepper M, Giulivi A (2000) Current status of hepatitis C in Canada. Can J Public Health 91:S10–S15

2. World Health Organization (1999) Global surveillance and control of hepatitis C—report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat 6:35–47

3. Health Canada (2001) A cost of illness study of the hepatitis C virus infection in Canada: a report to the Blood Borne Pathogens Division, Health Canada. Institute of Health Economics: Edmonton.

4. Zou S, Tepper M, El Saadany S (2000) Prediction of hepatitis C burden in Canada. Can J Gastroenterol 14:575–580

5. Briggs A, Sculpher M (1998) Introducing Markov models for economic evaluation. Pharmacoeconomics 13:397–409

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence and Associated Risk Factors of Hepatitis B and C among Inmates of Port Harcourt Maximum Security Custodial Centre;Advances in Infectious Diseases;2023

2. Priorities among effective clinical preventive services in British Columbia, Canada;BMC Health Services Research;2022-04-26

3. Prevalence of Hepatitis B and C Among Prison Inmates in India: A Systematic Review and Meta-Analysis;Cureus;2021-11-17

4. Prescribing trends in direct-acting antivirals for the treatment of hepatitis C in Ontario, Canada;Canadian Liver Journal;2021-02-01

5. Epidemiology: Modeling of Natural History;Hepatitis C: Epidemiology, Prevention and Elimination;2021